
Exposomics for better environmental health
The focus for World Environment Day in 2025 (June 5) is on ending plastic pollution. Micro-plastics represent one of the many thousands of chemical, physical and biological hazards that lurk in the air, water and living spaces for which we have neither the sensory capabilities nor sensing technologies to measure exposure and assess health risks. Thus, reducing the environmental disease burden continues to be a daunting challenge for public health.
In India, rapid economic growth is increasing the scale and the complexity of environmental exposures and the interdependencies between the living environment and lifestyles. With India already accounting for nearly 25% of the global environmental disease burden, there is a need to develop newer paradigms for environmental management that rest on integrated health risk assessments.
These must include all environmental factors into the study of disease development. The piece-meal approaches that define our current framing on environment or health indicators are likely to exaggerate environmental health inequities and result in spiralling health costs. We must embrace new and cutting-edge scientific developments in the field of 'exposomics' to gain a more complete picture of disease etiologies over the life course and develop holistic prevention strategies. Strategic investments in long-term environmental health surveillance that integrate novel environmental and biomonitoring efforts with digital health and data science platforms are critical.
Environmental disease burden
The World Health Organization (WHO) began estimating the environmental disease burden in 2000, which is the basis for the modern estimation approach being adopted in the Global Burden of Disease, Injuries, and Risk Factor (GBD) study. Each cycle of the GBD identifies risk factors with the greatest attributable health burden. In the latest cycle (2021) that included 88 risk factors, environmental and occupational (OEH) risk factors in the GBD were responsible for 18.9% (12.8 million) of global deaths and 14.4% of all disability-adjusted life years (DALYs), led by ambient PM 2.5 air pollution (4.2% DALYs, 4.7 million deaths) and household air pollution from the use of solid fuels for cooking (3.9% DALYs, 3.1 million deaths).
In India, nearly three million deaths and 100 million deaths are attributable to occupational and environmental health (OEH) risks. OEH risk factors in India are also estimated to account for more than 50% of the attributable burden for non-communicable diseases including ischemic heart disease, stroke, chronic obstructive lung disease, lung cancer, asthma and, more recently, diabetes and chronic kidney disease. Risk factors such as lead exposures can have grave developmental health impacts for children under five, with India accounting for up to 154 million or 20% of the total estimated IQ points lost globally in children under five.
What are we missing? The GBD results provide a strong and robust body of evidence to initiate actions for cleaner air, safer water and better sanitation. However, the current environmental burden of disease addresses only a limited number (around 11) of categories of environmental risk factors as there is a paucity of human exposure data. Several environmental risk factors that can contribute to significant health burdens are currently not included in the GBD. These include various chemical exposures, risks from complex mixtures such as micro-plastics and solid waste and physical hazards such as environmental noise.
More importantly, environmental risk factors interact in complex ways with metabolic (high blood pressure or high fasting plasma glucose) and behavioural risk factors (smoking and unhealthy diets) as well as underlying genetic susceptibility and upstream health determinants (such as socio-economic status) to produce a health impact within populations. Risk estimates are often derived for single risk factors; while confounding is often well adjusted in long-term cohort studies, complex mixtures and interactions over a life course have not been adequately explored.
Finally, climate change can magnify hazards posed by multiple environmental risk factors, such as heat, air pollution, vector-borne diseases, storms and flooding, and wildfires. Climate change may reduce crop yields, reduce agricultural worker productivity, disrupt food security and affect food supply chains. Depression, anxiety and other mental health outcomes, driven by both ecological concerns and direct health impacts of climate-sensitive environmental risk factors such as fine particulate matter, are also important to consider. Several of these risk factors can occur together, resulting in compound events and synergistic effects. These hazards can further amplify health impacts among populations with inadequate access to health systems or healthy food systems. Methods and data are not yet available to support inclusion of these important risk factors in the global burden of disease assessments.
Thus, the current environmental burden of disease estimates are not only a conservative underestimates but also do not provide an adequate means of prioritising against competing risk factors to develop holistic, scalable preventive health strategies.
The human exposome
The global human genome project (1990-2003) revolutionised our ability to explore the genetic origins of disease. However, it also revealed the limited predictive power of individual genetic variation for many common diseases. Genetic factors for example, contribute to less than half of the risk of heart disease, which is a leading source of mortality.
The success in mapping the human genome has fostered the complementary concept of the 'exposome'. The exposome is defined as the measure of all the exposures of an individual in a lifetime and how those exposures relate to health. Traditional environmental health studies include hypothesis-driven methods which have focused on one or a class of environmental exposures at a few time points. These fail to account for the complex interactions of exposures across the lifespan, on human health.
Exposomics aims to bridge this gap by understanding how external exposures from physical, chemical, biological and psycho-social environments interact with diet and lifestyle and internal individual characteristics such as genetics, physiology, and epigenetics to create health or disease. This would allow the generation of an atlas of exposure wide associations (EWAS) to complement genome-wide associations (GWAS) and enable discovery-based analysis of environmental influences on health. The exposome requires synchronisation of several inter-disciplinary technologies which include real time sensor based personal exposure monitoring with wearables; untargeted chemical analyses on human biomonitoring samples; testing on human-relevant micro-physiological systems (also known as organs-on-a-chip) wherein in vitro models replicate the structure and function of human organs or tissues to understand the mechanistic basis of biological response; and big data, and artificial intelligence (AI) to mine data and generate integrated pieces of evidence.
Given that capacities and resources to generate exposomics data are not widely available, an immediate need for the exposomic framework to become a reality is also the creation of a data ecosystem in which harmonised data can be found, accessed, and shared through sustained and interoperable data repositories.
Mainstream environment within health
Exposome frameworks may seem implausible or irrelevant in India where the implementation of environmental health management programmes faces numerous hurdles. But, leapfrogging to technology and data-driven approaches is not new to the health sector. Exposomics offers unprecedented potential to mainstream environmental risks within public health programmes by generating more accurate predictive models for many chronic diseases while also enabling precision medicine. Unbridled investments in capacity building and synchronising available analytical, environmental and public health infrastructure offer the promise of addressing the concerns of our populations with unprecedented cost-effectiveness. The time is ripe for the Indian environmental health community to engage and contribute to the global momentum on the science of exposomics.
Future celebrations of World Environment Day may soon focus on why the human exposome project can be the best prescription for holistic prevention efforts that preserve and promote health equity.
Dr. Kalpana Balakrishnan is Dean (Research), Sri Ramachandra Institute of Higher Education and Research (SRIHER), Chennai
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New Indian Express
14 minutes ago
- New Indian Express
Covid infections growing milder, occasional surges expected but don't worry: experts
The death toll is 55 in the current surge which started January this year, primarily among individuals with pre-existing illnesses, according to the Union Health ministry. "People with pre-existing illnesses and those older than 65 should follow standard precautions, as they would against any other respiratory infection -- not just for COVID-19," explained Lahariya, a consultant physician and former staff member of WHO. Kerala is the most affected with over 1,600 cases, followed by Gujarat, West Bengal, Delhi and Maharashtra, ministry data shows. The case surge in India is part of a wider wave impacting parts of Southeast Asia, including Singapore, Malaysia, Thailand and Hong Kong, which have been seeing a rise in infections over the past months. Wastewater surveillance by the Council of Scientific and Industrial Research-National Chemical Laboratory (NCL) has detected presence of SARS-CoV-2 -- which causes COVID-19 -- in samples from 10 sewage treatment plants in Pune, the Times of India reported. Patterns are similar to those seen in the weeks preceding earlier surges, NCL scientists were quoted as saying. Genome sequencing of samples from India's west and south have shown links to the subvariants of Omicron -- LF.7, XFG, JN.1 and NB.1.8.1. The cases are not severe and there is no need to worry, Director General of Indian Council of Medical Research (ICMR) Rajiv Behl said earlier this week. LF.7 and been classified as 'variants under monitoring' (VUM) by the WHO to alert public health authorities that a variant of SARS-CoV-2 requires prioritised attention and monitoring. JN.1 has been circulating in India since November 2023. The current situation, Behl stressed, is being monitored. Immunologist Satyajit Rath explained that the subvariants driving up case numbers indicate that they are probably better at binding themselves to human cells, despite pre-existing antibodies created in response to a prior infection or vaccination -- or 'infectivity'. "However, the important issue here is not their infectivity, but their tendency to cause severe disease, or 'virulence'," Rath, former scientist at New Delhi's National Institute of Immunology, told PTI. "Since selection pressure among the virus strains depends on infectivity and transmissibility -- and not on virulence -- there is no reason to expect a steady increase in the virulence of the emerging virus strains, which, in fact, has not at all been seen either," he added. Moreover, given that the COVID-19-causing virus is now endemic and constantly 'mutating' or evolving, ups and downs in infections in the population are expected, the health experts said. "People need not worry themselves until they are informed of a new 'variant of concern'. VUM is not relevant to the public, but only to public health authorities," Agarwal said. Lahariya advised the public to gather information from reliable sources and not to forward unverified messages, while Rath suggested that citizens keep a watch for the virulence of newly emerging strains. The experts also stressed on the role of authorities. "National and state governments in India should keep a watch on cases, monitor the trends in new cases and share data widely. The linkage between infections and clinical outcomes should be explored to understand the clinical features of the variants in circulation," Lahariya said. Rath drew attention to systemic issues that remain regarding preparedness of public health systems and availability of healthcare facilities across sections of the society should a virulent variant emerge. "The catch is, how efficiently, systematically and rigorously are our public health systems tracking virus strains, their infectivity and their virulence, not only for SARS-CoV-2 but for any other infection?" he asked. "Are we making next generation Covid vaccines at all? Are we making them available widely and affordably? Are we even carefully tracking evidence to see how well or poorly the current vaccine-induced immunity functions against emerging strains?" he added. The poor and vulnerable would need special protection "but are masks being made widely and freely available? And if not, we are throwing poor communities onto their own resources even for taking such simple precautions, and that is a systemic problem," Rath said.


United News of India
an hour ago
- United News of India
India's active Covid-19 cases near 6,000 as Kerala, Gujarat lead uptick
New Delhi, June 6 (UNI) India is witnessing a slow uptick in Covid-19 cases, with active infections being reported from nearly every state, except Arunachal Pradesh. As of 8 am on June 6, the total number of active infections across the country has reached 5,862, according to the Union Ministry of Health and Family Welfare. Four deaths have been reported in the last 24 hours against seven fatalities a previous day. Kerala continues to report the highest daily caseload as it recorded 192 new infections in the past 24 hours, taking its active case tally to 1,679. Two Covid-related deaths were also reported from the state on June 5. Following Kerala, Gujarat has emerged as the second-most affected state in terms of daily new cases, reporting 107 new infections during the same period while its current active caseload stands at 615. The national capital Delhi reported 30 new cases, with the city having recorded seven deaths related to Covid-19 since January 1, 2025. What could be a matter of concern to the authorities, states including Delhi, Maharashtra, and Gujarat have crossed the 500 active cases mark. Health authorities have urged citizens to re-adopt basic preventive measures such as masking in crowded places, maintaining hand hygiene, and staying home if symptomatic. Hospitals and district health centres have been directed to ensure that oxygen beds and ICU facilities are prepared, particularly for patients with comorbidities. Globally, the World Health Organization (WHO) has reported a rise in COVID-19 test positivity rates to 11% across 73 countries, mirroring peaks last seen in July 2024. The increase is driven by new emerging variants, including NB.1.8.1, particularly affecting the Eastern Mediterranean, South-East Asia, and Western Pacific regions. UNI AJ PRS


India.com
3 hours ago
- India.com
Covid in India latest update: Active cases rise to 5364, Delhi reports 562 cases, Maharashtra at..., Kerala leads with...,
Covid in India latest update: Active cases rise to 5364, Delhi reports 562 cases, Maharashtra at..., Kerala leads with..., India is once again witnessing a big rise in COVID-19 cases across the country. As of now, the number of active COVID-19 cases in the country stands at 5,364. At the same time, 4,724 people have recovered and been discharged from hospitals and home isolation across different states. Kerala leads the chart with 1,679 cases, followed by Gujrat (615), West Bengak (596) and Delhi (562). Here's a quick look at active cases in some major states: Delhi – 562 cases Gujarat – 615 cases Karnataka – 451 cases Kerala – 1,679 cases Maharashtra – 548 cases Rajasthan – 107 cases Tamil Nadu – 221 cases Uttar Pradesh – 205 cases West Bengal – 596 cases Unfortunately, four COVID-related deaths have also been reported. Karnataka: 1 Death A 65-year-old man passed away. He was also suffering from high blood pressure and uncontrolled diabetes. His COVID-19 infection was found incidentally while treating other conditions. Kerala: 2 Deaths A 74-year-old woman, who had multiple health problems including severe heart valve disease, COPD, high blood pressure, and diabetes, died after testing positive for COVID-19. A 79-year-old man, also from Kerala, passed away. He had high blood pressure, a history of stroke, liver disease, and a urinary tract infection caused by bacteria. Punjab: 1 Death A 69-year-old woman lost her life. She had pulmonary thromboembolism (a serious lung condition), along with morbid obesity. Health officials continue to keep a close watch on the situation. People, especially those with other health issues, are advised to take precautions and avoid crowded places if feeling unwell. PTI INFOGRAPHICS on covid cases across India Covid Variants As of May 2025, the World Health Organization (WHO) has identified LF.7 and NB.1.8.1 as Variants Under Monitoring. This means these new subvariants of the COVID-19 virus are being closely watched but are not yet classified as Variants of Concern (VOC) or Variants of Interest (VOI). However, health experts believe that these strains may be playing a role in the recent spike in infections, not only in India, but also in China and other parts of Asia. While more research is still underway, authorities are urging the public to remain cautious, especially those with underlying health conditions or weakened immunity. Even though new COVID-19 subvariants are being detected, JN.1 is still the most common strain in India. It makes up a massive 53% of all positive cases across the country right now. According to the latest report from the Indian SARS-CoV-2 Genomics Consortium (INSACOG): One case of the subvariant NB.1.8.1 was found in Tamil Nadu in April. Four cases of LF.7 were identified in Gujarat earlier in June. Health experts say that while these newer strains are being closely monitored, JN.1 remains the main cause behind the current wave of infections. People are being urged to stay cautious, especially those with health risks or low immunity.